Latest News > Tumor

Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco.

The new Business Insights report Cancer Market Outlook to 2014: Competitive landscape, market size, pipeline analysis and growth opportunities looks into what the future holds for players in the fastest growing pharmaceutical market.

Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body.

Venus Day Has Been Recognized for her Volunteer Work by Jeb Bush, the Governor of Florida as a Point of Light Award Recipient

A study to develop a new genetically engineered vaccine opened officially Oct 16. The program has begun screening patients. Initial clinical trial reported rapid shrinkage and/or disappearance of widespread tumors within eight weeks.

Glioblastoma patient using experimental vaccine consisting of his own brain tumor tissue and white blood cells showing results

A new, robotic-assisted minimally invasive thyroid surgery can now offer those with thyroid tumors relief without neck scars. This new procedure is being performed using the daVinci® Surgical System at College Station Medical Center in Texas.

--- NanoTecNexus and NanoTumor Center Education Projects Rank High ---

Korean-FDA approved RNL’s Astrostem based on patient’s own fat derived stem cells to treat spinal cord injury. Phase I human trial will be done by intravenous infusion of stem cells at Sam Hospital in Anyang, South Korea

Dr.. R.K. Mishra, holding Master Degree in Mimimal Access has successfully removed a 20-Kg tumour, known as retroperitoneal tumour from the abdomen of a patient.

Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement.

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.

Melanoma, a malignant tumor that arises in melanocytes, is the most deadly of all skin cancers.